Merck wrote drug studies for doctors
New York Times, April 17, 2008
Drug maker Merck drafted dozens of research studies for a best-selling drug, then lined up prestigious doctors to put their names on the reports before publication, according to a report. The report provides a look in the industry practice of ghostwriting medical research studies that are then published in academic journals. The authors of the study say it raises broad questions about the validity of much of the drug industry's published research, because the ghostwriting practice appears to be widespread.
- 'Kafkaesque' Value System Unfairly Penalizes Doctor Pay
- Proton Beam Therapy Poised for Growth in US
- mHealth Tackles Readmissions
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Targeting Self-Insured Populations
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- MA an Insurance Proving Ground for Providers
- 4 Crucial Tactics for Reining in Healthcare Cost
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- Docs Fret as HHS Addresses Malpractice Reporting 'Loopholes'